BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31361649)

  • 21. Radioiodine therapy for thyroid cancer depicted uterine leiomyoma.
    Hirata K; Shiga T; Kubota KC; Okamoto S; Kamibayashi T; Tamaki N
    Clin Nucl Med; 2009 Mar; 34(3):180-1. PubMed ID: 19352287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer.
    Ahn BC; Lee SW; Lee J; Kim C
    Thyroid; 2011 May; 21(5):555-8. PubMed ID: 21449768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.
    Lee CH; Jung JH; Son SH; Hong CM; Jeong JH; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2018; 13(8):e0202644. PubMed ID: 30118516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
    Patel DR; Kamat BH; Farwell MD
    Clin Nucl Med; 2017 Jan; 42(1):70-72. PubMed ID: 27846002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine-131 uptake in a menstruating uterus: value of SPECT/CT in distinguishing benign and metastatic iodine-positive lesions.
    Rachinsky I; Driedger A
    Thyroid; 2007 Sep; 17(9):901-2. PubMed ID: 17956166
    [No Abstract]   [Full Text] [Related]  

  • 26. A false-positive I-131 finding of duodenum diverticulum in thyroid cancer evaluation by SPECT/CT: A case report.
    Wang R; Zhou K; Fan Q; Chen H; Fan C
    Medicine (Baltimore); 2018 Feb; 97(8):e9997. PubMed ID: 29465605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography.
    Chander S; Meltzer CC; McCook BM
    Clin Nucl Med; 2002 Jan; 27(1):22-4. PubMed ID: 11805479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary Nasolacrimal Duct Obstruction Visualized on
    Kay MD; Morris-Wiseman LF; Beazer A; Winegar BA; Kuo PH
    J Nucl Med Technol; 2020 Mar; 48(1):77-78. PubMed ID: 31604890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidentally polycystic kidney disease identified by SPECT/CT with post-therapy radioiodine scintigraphy in a patient with differentiated thyroid carcinoma: A case report.
    Mi YX; Sui X; Huang JM; Wei LG; Xie P
    Medicine (Baltimore); 2017 Oct; 96(43):e8348. PubMed ID: 29069013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
    Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
    J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False-Positive 131I Uptake in a Benign Bone Lesion on Post-therapy Scan.
    Yazici B; Oral A; Eraslan C; Argin M; Ömür Ö
    Clin Nucl Med; 2016 Jan; 41(1):e63-5. PubMed ID: 26252335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental finding of a dermoid cyst in a whole-body iodine scan: importance of using [131I]SPECT/CT in the differentiated thyroid carcinoma.
    Mohammadzadeh Kosari H; Zakavi SR; Barashki S; Roustaei Firouzabad H; Ataei Nakhaei S; Aryana K
    Nucl Med Rev Cent East Eur; 2021; 24(2):106-107. PubMed ID: 34382676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial.
    Jin Y; Ruan M; Cheng L; Fu H; Liu M; Sheng S; Chen L
    Thyroid; 2019 Jan; 29(1):101-110. PubMed ID: 30560716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental focal uptake in oropharynx due to lingual thyroid on diagnostic 131I whole-body scan after total thyroidectomy.
    Song HS; Yoon SH; Jo KS; Lee DH; An YS; Yoon JK; Lee SJ
    Clin Nucl Med; 2013 Aug; 38(8):646-8. PubMed ID: 23640232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased 131I accumulation in the polyacrylamide hydrophilic gel used for breast augmentation.
    Lv J; Qu Y; Zhang M; Pan Y; Zhang Y
    Clin Nucl Med; 2014 Apr; 39(4):415-6. PubMed ID: 24566417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidental finding of ovarian teratoma on post-therapy scan for papillary thyroid cancer and impact of SPECT/CT imaging.
    Jammah AA; Driedger A; Rachinsky I
    Arq Bras Endocrinol Metabol; 2011 Oct; 55(7):490-3. PubMed ID: 22147099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Value of
    Gao R; Zhang GJ; Wang YB; Liu Y; Wang F; Jia X; Liang YQ; Yang AM
    Sci Rep; 2018 Jan; 8(1):473. PubMed ID: 29323252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nabothian cyst a predominant cause of false-positive iodine uptake in uterus: comparison of SPECT/CT and pelvic MRI.
    Isoda T; BaBa S; Maruoka Y; Kitamura Y; Nishie A; Sasaki M; Honda H
    Clin Nucl Med; 2014 Aug; 39(8):680-4. PubMed ID: 24978344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.